Workers Confuse Active Ingredients: Manufacturing Errors at Johnson & Johnson



[ad_1]

Workers confuse active ingredients
Manufacturing Errors at Johnson & Johnson

A breakdown has occurred in the production of one lot of Johnson & Johnson’s corona vaccine. A total of 15 million cans are said to have been affected. The workers at the plant seem to have messed with the ingredients.

A lot of Johnson & Johnson (J&J) Covid-19 vaccine cannot be used due to a manufacturing defect. There was a problem with a drug substance for its vaccine that did not meet quality standards at the production facilities of a partner company, the US pharmaceutical company said.

The company did not disclose how many doses of vaccine were affected by the problem at contract manufacturer Emergent Biosolutions. According to a “New York Times” report, there are said to be about 15 million doses of the vaccine. Workers at the plant that makes the J&J and Astrazeneca vaccines accidentally mixed the ingredients of the two vaccines a few weeks ago, the newspaper reported. Federal officials would attribute the error to human error.

The error was reported to the FDA health authority and there are now more employees to monitor production in the US state of Maryland, J&J said. There are still plans to deliver 100 million cans to the US government by the end of May, as previously promised. The J&J vaccine works to its full effect after just one injection.

“Quality and safety remain our top priority,” the company said. The Emergent Biosolutions production facility has not yet been cleared by the FDA for the vaccine. However, the company is already preparing production in order to meet delivery targets.

[ad_2]